Ocugen Inc OCGN:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 08/11/22 EDT
2.70quote price arrow up+2.70 (UNCH)
Volume
108,885
Close
2.68quote price arrow down-0.15 (-5.30%)
Volume
6,551,009
52 week range
1.67 - 17.65
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.68
  • 52 Week High17.65
  • 52 Week High Date11/03/21
  • 52 Week Low1.67
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap580.41M
  • Shares Out216.57M
  • 10 Day Average Volume4.87M
  • Dividend-
  • Dividend Yield-
  • Beta4.26
  • YTD % Change-41.1

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.68
  • 52 Week High17.65
  • 52 Week High Date11/03/21
  • 52 Week Low1.67
  • 52 Week Low Date05/12/22
  • Market Cap580.41M
  • Shares Out216.57M
  • 10 Day Average Volume4.87M
  • Dividend-
  • Dividend Yield-
  • Beta4.26
  • YTD % Change-41.1

RATIOS/PROFITABILITY

  • EPS (TTM)-0.31
  • P/E (TTM)-8.78
  • Fwd P/E (NTM)-7.81
  • EBITDA (TTM)-62.658M
  • ROE (TTM)-54.51%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-58,552.65%
  • Debt To Equity (MRQ)1.53%

EVENTS

  • Earnings Date11/07/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ocugen Inc

There is no recent news for this security.

Profile

MORE
Ocugen, Inc. is a biopharmaceutical company focused on developing gene therapies to cure blindness diseases and developing vaccine for COVID-19. The Company's technology pipeline includes: COVID-19 Vaccine (0.5), Modifier Gene Therapy Platform and Novel Biologic Therapies for Retinal Diseases. COVID-19 Vaccine candidate is focused on developing, manufacturing and commercializing COVAXIN for the prevention of COVID-19 in humans in the Ocugen Covaxin Territory. COVAXIN is a...
Shankar Musunuri Ph.D.
Chairman of the Board, Chief Executive Officer
Address
11 GREAT VALLEY PARKWAY
Malvern, PA
19355
United States

Top Peers

SYMBOLLASTCHG%CHG
KZR
Kezar Life Sciences Inc
9.76-0.28-2.79%
AVTE
Aerovate Therapeutics Inc
23.86-0.44-1.81%
AUTL
Autolus Therapeutics PLC
3.46+0.08+2.37%
PHVS
Pharvaris NV
17.02+0.02+0.12%
TCDA
Tricida Inc
13.13-0.21-1.57%